Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice

References

• Fahad Ullah M. Breast Cancer: current Perspectives on the Disease Status. Adv Exp Med Biol. 2019;1152:51–64.
   PubMed Web of Science ®Google Scholar
• Anastasiadi Z, Lianos GD, Ignatiadou E, et al. Breast cancer in young women: an overview. Updates Surg. 2017;69(3):313–317.
   PubMed Web of Science ®Google Scholar
• Libson S, Lippman M. A review of clinical aspects of breast cancer. Int Rev Psychiatry. 2014;26(1):4–15.
   PubMed Web of Science ®Google Scholar
• MB A, VS R, ME J, et al. Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr Pharm Des. 2014;20(30):4879–4898.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dong Y, Fu H, et al. Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance. Biomaterials. 2021;269:120478.
   PubMed Web of Science ®Google Scholar
• Pereira RO, Luz LAD, Chagas DC, et al. Evaluation of the accuracy of mammography, ultrasound and magnetic resonance imaging in suspect breast lesions. Clinics (Sao Paulo). 2020;75:e1805.
   PubMed Web of Science ®Google Scholar
• Kuhl CK. Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: rationale, Concept, and Transfer to Clinical Practice. Annu Rev Med. 2019;70(1):501–519.
   PubMedGoogle Scholar
• Gao Y, Reig B, Heacock L, et al. Magnetic Resonance Imaging in Screening of Breast Cancer. Radiol Clin North Am. 2021;59(1):85–98.
   PubMed Web of Science ®Google Scholar
• de Leon A, Perera R, Nittayacharn P, et al. Ultrasound Contrast Agents and Delivery Systems in Cancer Detection and Therapy. Adv Cancer Res. 2018;139:57–84.
   PubMed Web of Science ®Google Scholar
• Cai WB, Yang HL, Zhang J, et al. The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging. Sci Rep. 2015;5(1):13725.
   PubMedGoogle Scholar
• Tyler B, Gullotti D, Mangraviti A, et al. Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv Drug Deliv Rev. 2016;107:163–175.
   PubMed Web of Science ®Google Scholar
• Singhvi MS, Zinjarde SS, Gokhale DV. Polylactic acid: synthesis and biomedical applications. J Appl Microbiol. 2019;127(6):1612–1626.
   PubMed Web of Science ®Google Scholar
• Lim EH, Danthi N, Bednarski M, et al. A review: integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis. Nanomedicine. 2005;1(2):110–114.
   PubMed Web of Science ®Google Scholar
• Nieberler M, Reuning U, Reichart F, et al. Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers (Basel). 2017;9(9):116.
   PubMed Web of Science ®Google Scholar
• Hercbergs A. Clinical Implications and Impact of Discovery of the Thyroid Hormone Receptor on Integrin alphavbeta3-A Review. Front Endocrinol (Lausanne). 2019;10:565.
   PubMed Web of Science ®Google Scholar
• Mariano RN, Alberti D, Cutrin JC, et al. Design of PLGA based nanoparticles for imaging guided applications. Mol Pharm. 2014;11(11):4100–4106.
   PubMedGoogle Scholar
• Li Y, Hao L, Liu F, et al. Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy. Int J Nanomedicine. 2019;14:5875–5894.
   PubMed Web of Science ®Google Scholar
• Samuel G, Nazim U, Sharma A, et al. Selective Targeting of the Novel CK-10 Nanoparticles to the MDA-MB-231 Breast Cancer Cells. J Pharm Sci. 2021. DOI:10.1016/j.xphs.2021.12.014.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang W, Zhu X, et al. Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11. Bioengineered. 2021;12(2):11506–11519.
   PubMed Web of Science ®Google Scholar
• Ye G, Wang P, Xie Z, et al. IRF2-mediated upregulation of lncRNA HHAS1 facilitates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by acting as a competing endogenous RNA. Clin Transl Med. 2021;11(6):e429.
   PubMed Web of Science ®Google Scholar
• Zhong C, Tao B, Tang F, et al. Remodeling cancer stemness by collagen/fibronectin via the AKT and CDC42 signaling pathway crosstalk in glioma. Theranostics. 2021;11(4):1991–2005.
   PubMed Web of Science ®Google Scholar
• Barzaman K, Karami J, Zarei Z, et al. Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.
   PubMed Web of Science ®Google Scholar
• McPeak PR. Advancements in molecular breast imaging. Radiol Technol. 2014;85(5):523M-538M; quiz 539M-541M.
   PubMedGoogle Scholar
• Ratzinger G, Agrawal P, Körner W, et al. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Biomaterials. 2010;31(33):8716–8723.
   PubMed Web of Science ®Google Scholar
• Poonaki E, Esfandyar M, Hejazinia H, et al. N-acetylcysteine-PLGA nano-conjugate: effects on cellular toxicity and uptake of gadopentate dimeglumine. IET Nanobiotechnol. 2020;14(6):470–478.
   PubMed Web of Science ®Google Scholar
• Cahalane C, Bonezzi J, Shelestak J, et al. Targeted Delivery of Anti-inflammatory and Imaging Agents to Microglial Cells with Polymeric Nanoparticles. Mol Pharm. 2020;17(6):1816–1826.
   PubMedGoogle Scholar
• Ao M, Wang Z, Ran H, et al. Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent–a feasibility research. J Biomed Mater Res Part B Appl Biomater. 2010;93(2):551–556.
   PubMed Web of Science ®Google Scholar
• Li Q, Li C, Tong W. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging. J Nanosci Nanotechnol. 2016;16(6):5569–5576.
   PubMed Web of Science ®Google Scholar
• Li X, Feng Q, Jiang X. Microfluidic Synthesis of Gd-Based Nanoparticles for Fast and Ultralong MRI Signals in the Solid Tumor. Adv Healthc Mater. 2019;8(20):e1900672.
   PubMed Web of Science ®Google Scholar
• Liu J, Cheng K, Yang C, et al. Application of Triarylboron Substituted with Cyclic Arginine-Glycine-Aspartic Acid Motifs as a Multivalent Two-Photon Fluorescent Probe for Tumor Imaging in Vivo. Anal Chem. 2019;91(9):6340–6344.
   PubMed Web of Science ®Google Scholar
• Pathak V, Nolte T, Rama E, et al. Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles. Biomaterials. 2021;275:120896.
   PubMed Web of Science ®Google Scholar
• Yadav AS, Radharani NNV, Gorain M, et al. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer. Nanoscale. 2020;12(19):10664–10684.
   PubMed Web of Science ®Google Scholar
• Grabher BJ. Breast Cancer: evaluating Tumor Estrogen Receptor Status with Molecular Imaging to Increase Response to Therapy and Improve Patient Outcomes. J Nucl Med Technol. 2020;48(3):191–201.
   PubMed Web of Science ®Google Scholar
• Li X, Xia S, Zhou W, et al. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer. Int J Nanomedicine. 2019;14:2397–2413.
   PubMed Web of Science ®Google Scholar